PTPRK and primary central nervous system lymphoma: Additionally, a tumour suppressor function has been indicated for PTPκ (PTPRK) in primary central nervous system lymphomas [13], and PTPδ (PTPRD) in laryngeal squamous cell carcinoma and other human cancers [14].